ATC Group: J05AH Neuraminidase inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AH in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J05 Antivirals for systemic use
3 J05A Direct acting antivirals
4 J05AH Neuraminidase inhibitors

Group J05AH contents

Code Title
J05AH01 Zanamivir
J05AH02 Oseltamivir
J05AH03
J05AH04

Active ingredients in J05AH

Active Ingredient

Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body.

Peramivir is an inhibitor of influenza virus neuraminidase, an enzyme that releases viral particles from the plasma membrane of infected cells and is also important for viral entry into uninfected cells, which causes further spread of infectious virus in the body.

Zanamivir is an inhibitor of influenza virus neuraminidase, an enzyme that releases viral particles from the plasma membrane of infected cells and promotes virus spread in the respiratory tract. The activity of zanamivir is extracellular. It reduces the propagation of both influenza A and B viruses by inhibiting the release of infectious influenza virions from the epithelial cells of the respiratory tract.

Related product monographs

Document Type Information Source  
 DECTOVA Solution for infusion MPI, EU: SmPC European Medicines Agency (EU)
 EBILFUMIN Hard capsule MPI, EU: SmPC European Medicines Agency (EU)
 NATFLU Hard capsule MPI, Generic Health Sciences Authority (SG)
 OSELFLU Gelatin capsule MPI, Generic Health Products Regulatory Authority (ZA)
 RELENZA Inhalation powder, pre-dispensed MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TAMIFLU Hard capsule MPI, EU: SmPC European Medicines Agency (EU)
 TAMIFLU Powder for oral suspension MPI, EU: SmPC European Medicines Agency (EU)